Literature DB >> 19535021

Determination of ligustilide in rat brain after nasal administration of essential oil from Rhizoma Chuanxiong.

Jianming Guo1, Jin-ao Duan, Er-xin Shang, Yuping Tang, Dawei Qian.   

Abstract

A simple and sensitive HPLC-UV method was developed to determine ligustilide in rat brain samples after nasal administration. The lower limit of quantification (LLOQ) was 245 ng/ml for ligustilide. The calibration curve was linear over a concentration range of 245-4900 ng/ml. Brain samples were obtained at regular time intervals after nasal administration of ligustilide (45 mg/kg). Ligustilide could be detected in rat brain only after 5 min of nasal administration; which showed that ligustilide may have a rapid onset of action. This result illustrates that intranasal administration of ligustilide may act as a promising alternative to conventional routes of administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535021     DOI: 10.1016/j.fitote.2009.01.003

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  5 in total

1.  Umbellulone modulates TRP channels.

Authors:  Jian Zhong; Alberto Minassi; Jean Prenen; Orazio Taglialatela-Scafati; Giovanni Appendino; Bernd Nilius
Journal:  Pflugers Arch       Date:  2011-10-29       Impact factor: 3.657

2.  Z-ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells.

Authors:  Hongyi Qi; Jia Zhao; Yifan Han; Allan S Y Lau; Jianhui Rong
Journal:  Neurotox Res       Date:  2012-03-27       Impact factor: 3.911

3.  Ligustilide: a novel TRPA1 modulator.

Authors:  Jian Zhong; Federica Pollastro; Jean Prenen; Zhiming Zhu; Giovanni Appendino; Bernd Nilius
Journal:  Pflugers Arch       Date:  2011-09-06       Impact factor: 3.657

Review 4.  Phytochemical and pharmacological review of da chuanxiong formula: a famous herb pair composed of chuanxiong rhizoma and gastrodiae rhizoma for headache.

Authors:  Lu Wang; Jinming Zhang; Yanlong Hong; Yi Feng; Meiwan Chen; Yitao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-27       Impact factor: 2.629

5.  Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsy.

Authors:  Adriana Monserrath Orellana-Paucar; Tatiana Afrikanova; Joice Thomas; Yelaman K Aibuldinov; Wim Dehaen; Peter A M de Witte; Camila V Esguerra
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.